Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease

被引：0
作者：
Rawaha Ahmad
Andrey Postnov
Guy Bormans
Jan Versijpt
Mathieu Vandenbulcke
Koen Van Laere
机构：
[1] KU Leuven and University Hospitals Leuven,Department of Imaging & Pathology, Nuclear Medicine and Molecular Imaging
[2] University Hospital Leuven,Division of Nuclear Medicine
[3] National Research Nuclear University MEPhI,Laboratory for Radiopharmacy
[4] KU Leuven,Department of Neurology
[5] University Hospital Brussels,Old Age Psychiatry, Department of Psychiatry
[6] KU Leuven and University Hospitals Leuven,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2016年 / 43卷
关键词：
Cannabinoid type 2 receptor; CB; R; Neuroinflammation; PET imaging; Alzheimer’s disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2219 / 2227
页数：8
相关论文
共 50 条
[31]   Connecting Type 2 diabetes to Alzheimer's disease [J].
De Felice, Fernanda G. .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (12) :1297-1299
[32]   Cannabinoid System in Neurodegeneration: New Perspectives in Alzheimer's Disease [J].
Campillo, N. E. ;
Paez, J. A. .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2009, 9 (05) :539-559
[33]   Decreased α7 nicotinic acetylcholine receptor protein levels in sporadic Alzheimer's disease hippocampus [J].
Lee, DHS ;
D'Andrea, MR ;
Plata-Salaman, CR ;
Wang, HY .
ALZHEIMERS REPORTS, 2000, 3 (04) :217-220
[34]   Decreased soluble interleukin-6 receptor in cerebrospinal fluid of patients with Alzheimer's disease [J].
Hampel, H ;
Sunderland, T ;
Kötter, HU ;
Schneider, C ;
Teipel, SJ ;
Padberg, F ;
Dukoff, R ;
Levy, J ;
Möller, HJ .
BRAIN RESEARCH, 1998, 780 (02) :356-359
[35]   Radioligands for positron emission tomography imaging of cannabinoid type 2 receptor [J].
Spinelli, Francesco ;
Mu, Linjing ;
Ametamey, Simon M. .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2018, 61 (03) :299-308
[36]   In Vivo and Computational Studies on Sitagliptin's Neuroprotective Role in Type 2 Diabetes Mellitus: Implications for Alzheimer's Disease [J].
Mani, Vasudevan ;
Arfeen, Minhajul .
BRAIN SCIENCES, 2024, 14 (12)
[37]   Decreased phospholipase A(2) activity in the brain and in platelets of patients with Alzheimer's disease [J].
Gattaz, WF ;
Cairns, NJ ;
Levy, R ;
Forstl, H ;
Braus, DF ;
Maras, A .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1996, 246 (03) :129-131
[38]   The Role of the Progesterone Receptor Family in Alzheimer's Disease [J].
Zhu, Taiyang ;
Hua, Fang .
BIOCELL, 2025,
[39]   Brain 11C-ITMM PET to longitudinally assess type 1 metabotropic glutamate receptor availability in Alzheimer's disease [J].
Ishibashi, Kenji ;
Miura, Yoshiharu ;
Wagatsuma, Kei ;
Kameyama, Masashi ;
Ishii, Kenji .
JOURNAL OF NEUROIMAGING, 2021, 31 (05) :864-868
[40]   Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition [J].
Stumm, Christoph ;
Hiebel, Christof ;
Hanstein, Regina ;
Purrio, Martin ;
Nagel, Heike ;
Conrad, Andrea ;
Lutz, Beat ;
Behl, Christian ;
Clement, Angela B. .
NEUROBIOLOGY OF AGING, 2013, 34 (11) :2574-2584
12345